Literature DB >> 12794630

Cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy with malignant ventricular tachyarrhythmias.

Hidenobu Terai1, Masami Shimizu, Hidekazu Ino, Masato Yamaguchi, Kenshi Hayashi, Kenji Sakata, Masaru Kiyama, Tatsumi Hayashi, Masaru Inoue, Junichi Taki, Hiroshi Mabuchi.   

Abstract

BACKGROUND: Malignant ventricular tachyarrhythmia (VT) and sudden death are serious events in hypertrophic cardiomyopathy (HCM). However, the pathophysiology of this condition is not well understood. The objective of this study was to evaluate the relationship between cardiac sympathetic nerve activity and the occurrence of VT in HCM patients. Methods and results We studied iodine 123 metaiodobenzylguanidine scintigraphy and 24-hour ambulatory electrocardiographic monitoring in 44 HCM patients, 15 with VT (group A) and 29 without VT (group B). With planar I-123 metaiodobenzylguanidine imaging, the heart-to-mediastinum ratio for early and delayed acquisition and washout rate were calculated. Polar maps of left ventricular myocardium were divided into 20 segments, and the SD of uptake and washout rate in 20 segments were calculated as indices of regional variation. The global washout rate was significantly higher in group A than in group B (26.8 +/- 6.4% vs 17.4 +/- 5.7%, P <.0001), although other parameters including heterogeneity indices did not differ. The logistic multiple regression analysis also determined that washout rate was the most powerful predictor of VT in patients with HCM.
CONCLUSIONS: The occurrence of malignant VT in HCM may be associated with global cardiac sympathetic nerve activity rather than with the heterogeneity of this activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794630     DOI: 10.1016/s1071-3581(03)00362-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  31 in total

1.  Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.

Authors:  C Zhao; N Shuke; W Yamamoto; A Okizaki; J Sato; Y Ishikawa; T Ohta; N Hasebe; K Kikuchi; T Aburano
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

2.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

3.  Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations.

Authors:  G X Yan; W Shimizu; C Antzelevitch
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690

4.  Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.

Authors:  M Schäfers; T Wichter; H Lerch; P Matheja; T Kuwert; K Schäfers; M Borggrefe; G Breithardt; O Schober
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

5.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

Authors:  M Shimizu; N Sugihara; Y Kita; K Shimizu; Y Horita; K Nakajima; J Taki; R Takeda
Journal:  Br Heart J       Date:  1992-02

6.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.

Authors:  B J Maron; D D Savage; J K Wolfson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

7.  Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death.

Authors:  R M Watson; J L Schwartz; B J Maron; E Tucker; D R Rosing; M E Josephson
Journal:  J Am Coll Cardiol       Date:  1987-10       Impact factor: 24.094

8.  Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart.

Authors:  H Calkins; K Allman; S Bolling; M Kirsch; D Wieland; F Morady; M Schwaiger
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

9.  Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog. 13. Correlation of activation and refractory maps.

Authors:  W B Gough; R Mehra; M Restivo; R H Zeiler; N el-Sherif
Journal:  Circ Res       Date:  1985-09       Impact factor: 17.367

Review 10.  Sudden cardiac death in heart failure. The role of abnormal repolarization.

Authors:  G F Tomaselli; D J Beuckelmann; H G Calkins; R D Berger; P D Kessler; J H Lawrence; D Kass; A M Feldman; E Marban
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

View more
  13 in total

Review 1.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

2.  Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.

Authors:  Satoshi Okayama; Shiro Uemura; Manabu Horii; Hiroyuki Kawata; Yoshihiko Saito
Journal:  J Nucl Cardiol       Date:  2008-07-26       Impact factor: 5.952

Review 3.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

4.  Heterogeneity of Ventricular Sympathetic Nervous Activity is Associated with Clinically Relevant Ventricular Arrhythmia in Postoperative Patients with Tetralogy of Fallot.

Authors:  Shin Ono; Hideo Ohuchi; Aya Miyazaki; Tadaaki Abe; Keisuke Kiso; Osamu Yamada
Journal:  Pediatr Cardiol       Date:  2015-05-16       Impact factor: 1.655

5.  Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

Authors:  Benedetto Vitiello; Glen R Elliott; James M Swanson; L Eugene Arnold; Lily Hechtman; Howard Abikoff; Brooke S G Molina; Karen Wells; Timothy Wigal; Peter S Jensen; Laurence L Greenhill; Jonathan R Kaltman; Joanne B Severe; Carol Odbert; Kwan Hur; Robert Gibbons
Journal:  Am J Psychiatry       Date:  2012-02       Impact factor: 18.112

6.  The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.

Authors:  Daniel Juneau; Fernanda Erthal; Benjamin J W Chow; Calum Redpath; Terrence D Ruddy; Juhani Knuuti; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2016-07-28       Impact factor: 5.952

Review 7.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

8.  Cardiac sympathetic nerve abnormality predicts ventricular tachyarrhythmic events in patients without conventional risk of sudden death.

Authors:  Yasushi Akutsu; Kyouichi Kaneko; Yusuke Kodama; Hui-Ling Li; Mitsuharu Kawamura; Taku Asano; Kaoru Tanno; Akira Shinozuka; Takehiko Gokan; Youichi Kobayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-12       Impact factor: 9.236

Review 9.  Multimodality imaging predictors of sudden cardiac death.

Authors:  Fancesco Bandera; Lilit Baghdasaryan; Giulia Elena Mandoli; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

Review 10.  The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy.

Authors:  Thomas Klein; Vasken Dilsizian; Qi Cao; Wengen Chen; Timm-Michael Dickfeld
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.